Drug Company Gift Disclosure Act

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 108th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

D DeFazioSponsor

30 cosponsors · 29 D, 1 I

21 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

What it does: CRS summary · Introduced in House · Feb 13, 2003

Drug Company Gift Disclosure Act - Amends the Federal Food, Drug, and Cosmetic Act to require drug manufacturers, packers, and distributors to disclose to the Commissioner of Food and Drugs the value, nature, and purpose of: (1) gifts made to covered health entities in connection with marketing activities; and (2) cash rebates, discounts, or any other financial consideration to any pharmaceutical benefit manager in connection with marketing activities. Makes such information available to the public, but retains the confidentiality of trade secrets. Establishes civil penalties for violations.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Drug Company Gift Disclosure Act

Latest action (Feb 26, 2003): Referred to the Subcommittee on Health.

Policy area: Commerce · Origin: House · Introduced: Feb 13, 2003

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.